The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Poliomyelitis Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
The global Poliomyelitis Vaccines market size is expected to reach US$ 5716.5 million by 2029, growing at a CAGR of 11.5% from 2023 to 2029. The market is mainly driven by the significant applications of Poliomyelitis Vaccines in various end use industries. The expanding demands from the Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others,, are propelling Poliomyelitis Vaccines market. IPV, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the OPV segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliomyelitis Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliomyelitis Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliomyelitis Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliomyelitis Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliomyelitis Vaccines covered in this report include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
The global Poliomyelitis Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Poliomyelitis Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliomyelitis Vaccines market, Segment by Type:
IPV
OPV
Global Poliomyelitis Vaccines market, by Application
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliomyelitis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliomyelitis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
The global Poliomyelitis Vaccines market size is expected to reach US$ 5716.5 million by 2029, growing at a CAGR of 11.5% from 2023 to 2029. The market is mainly driven by the significant applications of Poliomyelitis Vaccines in various end use industries. The expanding demands from the Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others,, are propelling Poliomyelitis Vaccines market. IPV, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the OPV segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliomyelitis Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliomyelitis Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliomyelitis Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliomyelitis Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliomyelitis Vaccines covered in this report include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.
The global Poliomyelitis Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Global Poliomyelitis Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliomyelitis Vaccines market, Segment by Type:
IPV
OPV
Global Poliomyelitis Vaccines market, by Application
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliomyelitis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliomyelitis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Poliomyelitis Vaccines Market Overview
1.1 Poliomyelitis Vaccines Product Overview
1.2 Poliomyelitis Vaccines Market Segment by Type
1.2.1 IPV
1.2.2 OPV
1.3 Global Poliomyelitis Vaccines Market Size by Type
1.3.1 Global Poliomyelitis Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Poliomyelitis Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Poliomyelitis Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poliomyelitis Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Poliomyelitis Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Poliomyelitis Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Poliomyelitis Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Poliomyelitis Vaccines Sales Breakdown by Type (2018-2023)
2 Global Poliomyelitis Vaccines Market Competition by Company
2.1 Global Top Players by Poliomyelitis Vaccines Sales (2018-2023)
2.2 Global Top Players by Poliomyelitis Vaccines Revenue (2018-2023)
2.3 Global Top Players by Poliomyelitis Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Poliomyelitis Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poliomyelitis Vaccines Market Competitive Situation and Trends
2.5.1 Poliomyelitis Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Poliomyelitis Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Poliomyelitis Vaccines Market
2.8 Key Manufacturers Poliomyelitis Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poliomyelitis Vaccines Status and Outlook by Region
3.1 Global Poliomyelitis Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Poliomyelitis Vaccines Historic Market Size by Region
3.2.1 Global Poliomyelitis Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Poliomyelitis Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Poliomyelitis Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Poliomyelitis Vaccines Forecasted Market Size by Region
3.3.1 Global Poliomyelitis Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Poliomyelitis Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Poliomyelitis Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Poliomyelitis Vaccines by Application
4.1 Poliomyelitis Vaccines Market Segment by Application
4.1.1 Research & Academic Laboratories
4.1.2 Pharmaceutical & Biotechnology Companies
4.1.3 Others
4.2 Global Poliomyelitis Vaccines Market Size by Application
4.2.1 Global Poliomyelitis Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Poliomyelitis Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Poliomyelitis Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poliomyelitis Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Poliomyelitis Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Poliomyelitis Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Poliomyelitis Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Poliomyelitis Vaccines Sales Breakdown by Application (2018-2023)
5 North America Poliomyelitis Vaccines by Country
5.1 North America Poliomyelitis Vaccines Historic Market Size by Country
5.1.1 North America Poliomyelitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Poliomyelitis Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Poliomyelitis Vaccines Sales in Value by Country (2018-2023)
5.2 North America Poliomyelitis Vaccines Forecasted Market Size by Country
5.2.1 North America Poliomyelitis Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Poliomyelitis Vaccines Sales in Value by Country (2024-2029)
6 Europe Poliomyelitis Vaccines by Country
6.1 Europe Poliomyelitis Vaccines Historic Market Size by Country
6.1.1 Europe Poliomyelitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Poliomyelitis Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Poliomyelitis Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Poliomyelitis Vaccines Forecasted Market Size by Country
6.2.1 Europe Poliomyelitis Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Poliomyelitis Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Poliomyelitis Vaccines by Region
7.1 Asia-Pacific Poliomyelitis Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Poliomyelitis Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Poliomyelitis Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Poliomyelitis Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Poliomyelitis Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Poliomyelitis Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Poliomyelitis Vaccines Sales in Value by Region (2024-2029)
8 Latin America Poliomyelitis Vaccines by Country
8.1 Latin America Poliomyelitis Vaccines Historic Market Size by Country
8.1.1 Latin America Poliomyelitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Poliomyelitis Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Poliomyelitis Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Poliomyelitis Vaccines Forecasted Market Size by Country
8.2.1 Latin America Poliomyelitis Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Poliomyelitis Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Poliomyelitis Vaccines by Country
9.1 Middle East and Africa Poliomyelitis Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Poliomyelitis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Poliomyelitis Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Poliomyelitis Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Poliomyelitis Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Poliomyelitis Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Poliomyelitis Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Poliomyelitis Vaccines Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Poliomyelitis Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Bibcol
10.3.1 Bibcol Company Information
10.3.2 Bibcol Introduction and Business Overview
10.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bibcol Poliomyelitis Vaccines Products Offered
10.3.5 Bibcol Recent Development
10.4 Serum Institute
10.4.1 Serum Institute Company Information
10.4.2 Serum Institute Introduction and Business Overview
10.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Serum Institute Poliomyelitis Vaccines Products Offered
10.4.5 Serum Institute Recent Development
10.5 Tiantan Biological
10.5.1 Tiantan Biological Company Information
10.5.2 Tiantan Biological Introduction and Business Overview
10.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tiantan Biological Poliomyelitis Vaccines Products Offered
10.5.5 Tiantan Biological Recent Development
10.6 IMBCA
10.6.1 IMBCA Company Information
10.6.2 IMBCA Introduction and Business Overview
10.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 IMBCA Poliomyelitis Vaccines Products Offered
10.6.5 IMBCA Recent Development
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Company Information
10.7.2 Panacea Biotec Ltd Introduction and Business Overview
10.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Products Offered
10.7.5 Panacea Biotec Ltd Recent Development
10.8 Bio-Med
10.8.1 Bio-Med Company Information
10.8.2 Bio-Med Introduction and Business Overview
10.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bio-Med Poliomyelitis Vaccines Products Offered
10.8.5 Bio-Med Recent Development
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Company Information
10.9.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Products Offered
10.9.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poliomyelitis Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poliomyelitis Vaccines Industrial Chain Analysis
11.4 Poliomyelitis Vaccines Market Dynamics
11.4.1 Poliomyelitis Vaccines Industry Trends
11.4.2 Poliomyelitis Vaccines Market Drivers
11.4.3 Poliomyelitis Vaccines Market Challenges
11.4.4 Poliomyelitis Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poliomyelitis Vaccines Distributors
12.3 Poliomyelitis Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
